OAM
CHTP

Oxford Asset Management’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Oxford Asset Management’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-63,694
Closed -$192K – 922
2013
Q3 		$192K Buy
63,694
+19,534
+44% +$56.1K ﹤0.01% 741
2013
Q2 		$102K Buy
+44,160
New +$89.3K ﹤0.01% 829

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oxford Asset Management's CHTP Position: Q4 2013 in Review

Oxford Asset Management sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q4 2013, closing a stake of 63,694 shares — an estimated $192K sold.

Oxford Asset Management first reported a position in CHTP in Q2 2013 and held it in 2 quarters. The position peaked at $192K in Q3 2013. 78 funds tracked by Wall St. Rank hold CHTP as of Q4 2013.

  • Oxford Asset Management reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q4 2013 after selling out during the quarter.
  • Oxford Asset Management sold 63,694 CHELSEA THERAPEUTICS INT'L LTD shares in Q4 2013, an estimated $192K.
  • Oxford Asset Management first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 2 quarters.
  • Oxford Asset Management's CHELSEA THERAPEUTICS INT'L LTD position peaked at $192K in Q3 2013.
  • 78 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q4 2013.

Based on Oxford Asset Management's 13F filing for Q4 2013, filed 22 Jan 2014.